AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,192,000 | +104.0% | 295,848 | -1.1% | 0.13% | +90.0% |
| Q2 2020 | $4,996,000 | +14.1% | 298,996 | -1.5% | 0.07% | -9.1% |
| Q1 2020 | $4,378,000 | -50.7% | 303,581 | +14.4% | 0.08% | -35.3% |
| Q4 2019 | $8,883,000 | +53.1% | 265,402 | -4.2% | 0.12% | +45.1% |
| Q3 2019 | $5,802,000 | +41.7% | 277,064 | +40.9% | 0.08% | +32.3% |
| Q2 2019 | $4,094,000 | -7.8% | 196,618 | -1.0% | 0.06% | -13.9% |
| Q1 2019 | $4,441,000 | -18.9% | 198,692 | -13.2% | 0.07% | -33.3% |
| Q4 2018 | $5,473,000 | +7.8% | 228,820 | +22.9% | 0.11% | +31.7% |
| Q3 2018 | $5,079,000 | – | 186,193 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |